About Zepteon
Zepteon is a company based in Boston (United States) founded in 2012. Zepteon has raised $210 thousand across 1 funding round. Zepteon offers products and services including Glycap-3A. Zepteon operates in a competitive market with competitors including Isolere Bio, ExBiome, REV-MED, VIRAPUR and Norgen Biotek, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zepteon, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$210 K (USD)
in 1 rounds
-
Latest Funding Round
$210 K (USD), Seed
Apr 09, 2015
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zepteon
Zepteon offers a comprehensive portfolio of products and services, including Glycap-3A.
Separates nonfucosylated or bisected IgG glycoforms for enhanced antibody production.
People of Zepteon
Unlock access to complete
Unlock access to complete
Funding Insights of Zepteon
Zepteon has successfully raised a total of $210K through 1 strategic funding round. The most recent funding activity was a Seed round of $210 thousand completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Zepteon
Investment portfolio details for Zepteon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zepteon
Detailed financials for Zepteon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zepteon Comparisons
Peer comparison for Zepteon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zepteon
Zepteon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Isolere Bio, ExBiome, REV-MED, VIRAPUR and Norgen Biotek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A platform for biotherapeutics purification is provided using TFF technology.
|
|
| Locked | Locked | Locked |
Develops innovative diagnostic technologies for cancer detection from blood samples.
|
|
| Locked | Locked | Locked |
Limited details on core medical activities are available.
|
|
| Locked | Locked | Locked |
Provides viral reagents and assay services for scientific and medical research.
|
|
| Locked | Locked | Locked |
Offers kits and services for RNA, DNA extraction, purification, and genomics research.
|
Detailed competitors of Zepteon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zepteon
Complete news archive for Zepteon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zepteon
Zepteon was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Zepteon is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Zepteon is a funded company, having raised a total of $210K across 1 funding round to date.
Founded in 2012 and based in Boston, United States, Zepteon operates in the biopharmaceutical sector. Technology focused on antibody development and manufacturing is provided through Glycap-3A chromatography resin, which separates high-potency antibodies from mixtures. This approach supports drug potency tuning, regulatory structure-function characterization, and production of biosimilars, biobetters, and novel therapeutics. Services are extended to monoclonal antibody and plasma-derived antibody markets via fees, milestones, and royalties.
Zepteon's top competitors include Isolere Bio, GenTegra and REV-MED.
Zepteon offers Glycap-3A.